肌钙蛋白I有助于深入了解心脏毒性以及蒽环类药物与曲妥珠单抗的相互作用。 - Suppr

Suppr

超能文献

Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction.

作者信息

Ewer Michael S, Ewer Steven M

出版信息

J Clin Oncol. 2010 Sep 1;28(25):3901-4. doi: 10.1200/JCO.2010.30.6274. Epub 2010 Aug 2.

DOI:10.1200/JCO.2010.30.6274

PMID:20679626

Abstract

摘要

相似文献

Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction.

J Clin Oncol. 2010 Sep 1;28(25):3901-4. doi: 10.1200/JCO.2010.30.6274. Epub 2010 Aug 2.

Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.

Nat Clin Pract Oncol. 2008 Jun;5(6):324-35. doi: 10.1038/ncponc1090. Epub 2008 Mar 25.

Adjuvant therapy for HER2 positive breast cancer: are anthracyclines still necessary?

Clin Adv Hematol Oncol. 2008 Sep;6(9):666-72.

J Clin Oncol. 2010 Jul 20;28(21):3407-10. doi: 10.1200/JCO.2009.26.0125. Epub 2010 Jun 7.

Re: Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.

Nat Clin Pract Oncol. 2008 Nov;5(11):E1. doi: 10.1038/ncponc1275.

Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation.

J Clin Oncol. 2010 Sep 1;28(25):3910-6. doi: 10.1200/JCO.2009.27.3615. Epub 2010 Aug 2.

Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?

J Clin Oncol. 2007 Dec 1;25(34):5532-3; author reply 5533-4. doi: 10.1200/JCO.2007.14.0657.

Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes.

Cardiovasc Toxicol. 2007;7(2):67-71. doi: 10.1007/s12012-007-0013-5.

Trastuzumab-induced cardiotoxicity: is it time for troponin for all patients?

Am J Clin Oncol. 2012 Apr;35(2):183-4. doi: 10.1097/COC.0b013e318214e01f.

Population pharmacokinetic-pharmacodynamic analysis of trastuzumab-associated cardiotoxicity.

Clin Pharmacol Ther. 2011 Jul;90(1):126-32. doi: 10.1038/clpt.2011.74. Epub 2011 Jun 1.

引用本文的文献

Review of the clinical status of cardiotoxicity of HER-2 positive breast cancer targeted therapeutic drugs.

Front Oncol. 2025 Feb 7;14:1492203. doi: 10.3389/fonc.2024.1492203. eCollection 2024.

Troponin Elevation in Asymptomatic Cancer Patients: Unveiling Connections and Clinical Implications.

Curr Heart Fail Rep. 2024 Dec;21(6):505-514. doi: 10.1007/s11897-024-00681-x. Epub 2024 Sep 10.

New Concepts in Cardio-Oncology.

Cancer Treat Res. 2023;188:303-341. doi: 10.1007/978-3-031-33602-7_12.

Optimizing combination therapy in a murine model of HER2+ breast cancer.

Comput Methods Appl Mech Eng. 2022 Dec 1;402. Epub 2022 Aug 17.

Cardioprotective Agents for the Primary Prevention of Trastuzumab-Associated Cardiotoxicity: A Systematic Review and Meta-Analysis.

Pharmaceuticals (Basel). 2023 Jul 9;16(7):983. doi: 10.3390/ph16070983.

Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection.

Front Cardiovasc Med. 2022 Apr 15;9:847012. doi: 10.3389/fcvm.2022.847012. eCollection 2022.

Comprehending Cardiac Dysfunction by Oxidative Stress: Untargeted Metabolomics of Samples.

Front Chem. 2022 Apr 8;10:836478. doi: 10.3389/fchem.2022.836478. eCollection 2022.

Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance.

Cardiol Res Pract. 2022 Feb 27;2022:1910841. doi: 10.1155/2022/1910841. eCollection 2022.

Heart Failure Therapies for the Prevention of HER2-Monoclonal Antibody-Mediated Cardiotoxicity: A Systematic Review and Meta-Analysis of Randomized Trials.

Cancers (Basel). 2021 Nov 3;13(21):5527. doi: 10.3390/cancers13215527.

Role of Cardiac Biomarkers in Cancer Patients.

Cancers (Basel). 2021 Oct 29;13(21):5426. doi: 10.3390/cancers13215426.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验